GSTM1 and anemia: The prevalence of anemia was 17.2% (median age: 69 years for anemic versus 65 years for nonanemic); after six months 43% of these anemic patients at baseline had normalized Hb levels, whereas 16% of the nonanemic patients had developed anemia.